lotilibcin (Kasten)

N/A

Report date: 2026/01/04 17:55:57

Base Information

Drug Namelotilibcin (Kasten)
Drug Alias Namelotilibcin
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArigen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesKasten Inc
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A